To study the molecular pathway of colorectal carcinoma, and its association with expression of other markers
Not Applicable
- Conditions
- Health Condition 1: C189- Malignant neoplasm of colon, unspecified
- Registration Number
- CTRI/2024/05/066689
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed and Histologically confirmed cases of colorectal carcinoma
Exclusion Criteria
Patients who have recieved prior chemotherapy/immunotherapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Proportion of cases of colorectal carcinoma with deficient mismatch repair (dMMR). <br/ ><br>2.Proportion of cases of colorectal carcinoma showing PD-L1 expressionTimepoint: Baseline
- Secondary Outcome Measures
Name Time Method 1.Association of MSI status and immunohistochemical expression of PD-L1 with clinicopathological parametersTimepoint: Baseline